BL
IDXX icon

BFSG LLC’s Idexx Laboratories IDXX Stock Holding History

BFSG LLC’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3
Closed -$1.67K – 682
2023
Q4 		$1.67K Buy
+3
New +$1.41K ﹤0.01% 551
2021
Q2 		– Sell
-1,626
Closed -$796K – 163
2021
Q1 		$796K Buy
+1,626
New +$815K 0.13% 149
2019
Q4 		– Sell
-2,201
Closed -$599K – 205
2019
Q3 		$599K Sell
2,201
-32
-1% -$8.9K 0.13% 123
2019
Q2 		$615K Sell
2,233
-79
-3% -$19.5K 0.24% 76
2019
Q1 		$517K Buy
+2,312
New +$477K 0.19% 95
2018
Q4 		– Sell
-1,918
Closed -$479K – 109
2018
Q3 		$479K Buy
+1,918
New +$466K 0.2% 99

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BFSG LLC's IDXX Position: Q1 2024 in Review

BFSG LLC sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 3 shares — an estimated $1.67K sold.

BFSG LLC first reported a position in IDXX in Q3 2018 and held it in 6 quarters. The position peaked at $796K in Q1 2021. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • BFSG LLC reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
  • BFSG LLC sold 3 Idexx Laboratories shares in Q1 2024, an estimated $1.67K.
  • BFSG LLC first reported a position in Idexx Laboratories in Q3 2018 and held it in 6 quarters.
  • BFSG LLC's Idexx Laboratories position peaked at $796K in Q1 2021.
  • 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on BFSG LLC's 13F filing for Q1 2024, filed 23 Apr 2024.